TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Alphramedic AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,767
|
4,201
|
4,026 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,050
|
533
|
625 |
| EBITDA |
1,027
|
532
|
625 |
| Total assets |
3,396
|
2,968
|
2,530 |
| Current assets |
3,396
|
2,968
|
2,530 |
| Current liabilities |
351
|
348
|
326 |
| Equity capital |
3,045
|
2,620
|
2,204 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.7%
|
88.3%
|
87.1% |
| Turnover per employee |
2,884
|
2,100
|
2,013 |
| Profit as a percentage of turnover |
18.2%
|
12.7%
|
15.5% |
| Return on assets (ROA) |
30.9%
|
18.0%
|
24.7% |
| Current ratio |
967.5%
|
852.9%
|
776.1% |
| Return on equity (ROE) |
34.5%
|
20.3%
|
28.4% |
| Change turnover |
1,566
|
175
|
766 |
| Change turnover % |
37%
|
4%
|
23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.